SRSF2 helps cells process RNA, the working copy of genetic information used to make proteins. If the SRSF2 gene does not work properly, cells may make the wrong protein instructions, and blood-forming cells can grow or mature in abnormal ways. In medicine, this gene is important because acquired variants in the SRSF2 gene are linked to several blood conditions, especially myelodysplastic syndromes, chronic myelomonocytic leukemia, and some acute myeloid leukemias. Most people hear about the SRSF2 gene through blood cancer testing rather than public media coverage.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or guide processes in the body. Some genes provide the information needed to produce proteins, the functional parts of cells. Other genes mainly help regulate when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to explore this topic in more detail, you can learn more in the LearnHub.
Overview
SRSF2Gene function
What if the gene works
The SRSF2 gene helps cells edit RNA instructions into mature messages, so proteins are made in the right form. It also helps control which messages are used in different tissues and stages of growth.
Risk
What if the gene does not work
Changes in the SRSF2 gene, usually acquired in blood-forming cells, can disrupt RNA splicing and contribute to myelodysplastic syndromes, chronic myelomonocytic leukemia, and some acute myeloid leukemia. Milder or more severe variants may shape which features develop.
Treatment
What does that mean for your treatment
No SRSF2-specific treatment or drug choice is currently established in clinical guidelines for people with pathogenic variants in the SRSF2 gene. In myeloid cancers, SRSF2 variants are being studied as biomarkers and as a clue for drugs that target RNA splicing, but these approaches remain investigational.
Conditions associated with SRSF2
Gene function
What if the gene works
Every day, your cells make rough RNA drafts that need careful editing before proteins can be built. The SRSF2 gene helps manage this step by guiding how those drafts are cut and rejoined. Understanding what the SRSF2 gene does helps explain how cells turn genetic instructions into clear working messages.
The SRSF2 gene helps cells trim and reconnect newly made RNA messages before they are used to build proteins. This step turns rough first drafts into clear instructions for the cell.
Its protein binds to specific spots on RNA and helps choose which pieces are kept or skipped. This allows one gene to produce different protein versions in a controlled way.
SRSF2 also helps RNA messages mature while genes are being read in the nucleus, the cell's control center. This supports smooth handoff of those messages for later protein production.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SRSF2 gene usually change how the protein recognizes RNA, so cells use the wrong cut and paste points in many RNA messages. How SRSF2 gene variants affect RNA splicing depends on the exact change: common hotspot variants, especially around P95, often redirect this process rather than shutting the protein off completely. Some changes have a stronger effect than others and, in blood-forming cells, may be linked to earlier or more pronounced disease features.
How variants are linked to conditions
Changes in the SRSF2 gene are most strongly linked to certain blood cancers, especially myelodysplastic syndromes, chronic myelomonocytic leukemia, and some cases of acute myeloid leukemia. In practice, SRSF2 gene variants linked to myelodysplastic syndrome are usually found in blood-forming cells and are part of the cancer itself rather than an inherited family trait. Their presence can help clinicians classify a myeloid cancer, but they do not by themselves predict exactly how the illness will affect one person.
A variant is not necessarily a diagnosis
Genetic variants are common and are a normal feature of being human. Most do not directly affect health and simply contribute to the natural differences seen across people. For many genes, a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific day-to-day factors that increase or reduce risk related to the SRSF2 gene. Changes in SRSF2 are most often found in blood cells over time rather than inherited, so personal risk is usually shaped by the wider blood condition, age, and overall health picture. Anyone worried about their risk should speak with a doctor or genetic counselor.
Inheritance of SRSF2 variants
For families asking how SRSF2 gene variants are inherited, there is not a broadly confirmed inherited pattern tied to a specific SRSF2 related condition. Most well-known SRSF2 gene changes are found only in blood or bone marrow cells during a person’s lifetime rather than being passed down through a family. The SRSF2 gene is located on chromosome 17, which is an autosome, so each person inherits one copy from each parent.
What does my SRSF2 result mean for my family?
There is not a broadly confirmed inherited family pattern tied to SRSF2 for a specific well-established genetic condition. Most SRSF2 changes discussed in health care are found only in blood or bone marrow cells during life rather than passed through families, so the meaning for relatives depends on the exact result.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the SRSF2 gene is usually done on blood or bone marrow as part of a myeloid cancer panel. If you are looking into how SRSF2 genetic testing works, the lab uses DNA sequencing to read the gene and look for acquired variants, which can help classify a blood condition.
When should I consider getting a genetic test?
Testing for changes in the SRSF2 gene can be worth considering if doctors are checking for certain blood cancers, especially conditions that affect bone marrow such as myelodysplastic syndromes or chronic myelomonocytic leukemia. In this setting, SRSF2 is usually tested as part of a blood or bone marrow gene panel to help confirm the diagnosis and plan care.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, yet how much it explains depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body functions. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else. These differences are common and are one part of why treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can shape a person’s response to medication. By looking at connections between genes and drugs, it helps clarify why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the SRSF2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about symptoms, treatment, or side effects are best discussed with your doctor. In blood cancers, SRSF2 changes are being studied to see whether they relate to response to some treatments, but this research is not yet used routinely to direct care.
History
The SRSF2 gene entered the scientific literature through work on how cells process RNA, the genetic message used to make proteins. Initially understood only through visible traits, later recognized as tied to a specific gene, it was first studied under the name SC35 in experiments that helped map the machinery of RNA splicing. From these first observations, research expanded steadily. As cancer genetics advanced, variants in the SRSF2 gene were identified in certain blood conditions, which brought the gene into a more clinical setting. This link helped connect basic laboratory discoveries with patient care. Over time, descriptions became more precise, and SRSF2 is now recognized as an important part of modern blood cancer research.